Drug Discovery

Mylan to launch two new HIV combination treatments in US

Mylan said that it will launch two new HIV treatments, Symfi Lo and Cimduo, which have been approved in February this year by the US Food and Drug Administration (FDA).

LEO Pharma sells major product portfolio to Karo Pharma for €260m

LEO Pharma has sold product portfolio of 10 products to Swedish company Karo Pharma for €260m.

AstraZeneca’s MedImmune spins out biotech to focus on autoimmune candidates

MedImmune, the global biologics research and development arm of AstraZeneca, is creating a stand-alone company for early-stage inflammation and autoimmunity biologics.

Senti Biosciences secures $53m funding to advance therapeutic design platform

Senti Biosciences has completed a $53m round of funding to support the expansion of their therapeutic design platform.

BenevolentAI buys drug discovery and development facility in Cambridge, UK

BenevolentAI has acquired an advanced drug discovery and development facility on the Babraham Research Campus in Cambridge, UK, for an undisclosed sum.

New collaborative project to develop Zika virus vaccine for pregnant women

A new collaborative project has been launched to develop a Zika virus vaccine that is suitable for use in pregnancy.

Kite, Sangamo form $3bn cancer cell therapy collaboration

Gilead Sciences’ subsidiary Kite has agreed to use Sangamo Therapeutics’ zinc finger nuclease (ZFN) technology platform to develop cancer treatments in a collaboration deal worth over $3bn.

Emulate, Roche partner to apply organ-chips to drug efficacy and safety

Scientists from Emulate and Roche have partnered to use Organ-Chips for testing of efficacy and safety of new antibody therapeutics and combination therapies.

ATUM, Just Biotherapeutics collaborate to speed up drug discovery

ATUM has signed a patent licensing agreement, which gives Just Biotherapeutics access to its Leap-In cell line development tools.